• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

    7/2/24 7:25:55 PM ET
    $RCM
    Other Consumer Services
    Consumer Discretionary
    Get the next $RCM alert in real time by email
    SC 13D/A 1 d819510dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 8)*

     

     

    R1 RCM Inc.

    (Name of Issuer)

     

     

    Common stock, par value $0.01 per share

    (Title of Class of Securities)

    77634L 105

    (CUSIP Number)

    New Mountain Capital, L.L.C.

    1633 Broadway, 48th Floor

    New York, New York 10019

    (212) 720-0300

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    July 2, 2024

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 2 of 14

     

    (1)   

    Names of reporting persons

     

    CoyCo 1, L.P.

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    Delaware

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    124,910,408

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    124,910,408

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    124,910,408

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    29.7%*

    (14)   

    Type of reporting person (see instructions)

     

    PN

     

    *

    Based on 421,255,230 shares of common stock (the “Common Stock”) of R1 RCM Inc. (the “Issuer”) outstanding as of May 6, 2024, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 8, 2024 (the “Form 10-Q”).


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 3 of 14

     

    (1)   

    Names of reporting persons

     

    CoyCo 2, L.P.

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    Delaware

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    11,075,180

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    11,075,180

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    11,075,180

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    2.6%*

    (14)   

    Type of reporting person (see instructions)

     

    PN

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 4 of 14

     

    (1)   

    Names of reporting persons

     

    CoyCo GP, L.L.C.

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    Delaware

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    135,985,588

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    135,985,588

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    135,985,588

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    32.3%*

    (14)   

    Type of reporting person (see instructions)

     

    OO

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 5 of 14

     

    (1)   

    Names of reporting persons

     

    New Mountain Partners V (AIV-D), L.P.

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    Delaware

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    135,985,588

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    135,985,588

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    135,985,588

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    32.3%*

    (14)   

    Type of reporting person (see instructions)

     

    PN

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 6 of 14

     

    (1)   

    Names of reporting persons

     

    New Mountain Investments V, L.L.C.

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    Delaware

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    135,985,588

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    135,985,588

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    135,985,588

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    32.3%*

    (14)   

    Type of reporting person (see instructions)

     

    OO

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 7 of 14

     

    (1)   

    Names of reporting persons

     

    New Mountain Capital, L.L.C.

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    Delaware

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    135,985,588

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    135,985,588

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    135,985,588

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    32.3%*

    (14)   

    Type of reporting person (see instructions)

     

    OO

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 8 of 14

     

    (1)   

    Names of reporting persons

     

    New Mountain Capital Group, L.P.

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    Delaware

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    135,985,588

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    135,985,588

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    135,985,588

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    32.3%*

    (14)   

    Type of reporting person (see instructions)

     

    PN

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 9 of 14

     

    (1)   

    Names of reporting persons

     

    NM Holdings GP, L.L.C.

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    Delaware

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    135,985,588

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    135,985,588

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    135,985,588

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    32.3%*

    (14)   

    Type of reporting person (see instructions)

     

    OO

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 10 of 14

     

    (1)   

    Names of reporting persons

     

    Steven B. Klinsky

    (2)   

    Check the appropriate box if a member of a group (see instructions)

    (a) ☐  (b) ☒

     

    (3)   

    SEC use only

     

    (4)   

    Source of funds (see instructions)

     

    OO

    (5)   

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

    (6)   

    Citizenship or place or organization

     

    United States of America

    Number of

    shares

    beneficially  

    owned by

    each

    reporting

    person

    with:

       (7)   

    Sole voting power

     

    0

       (8)   

    Shared voting power

     

    135,985,588

       (9)   

    Sole dispositive power

     

    0

       (10)   

    Shared dispositive power

     

    135,985,588

    (11)   

    Aggregate amount beneficially owned by each reporting person

     

    135,985,588

    (12)   

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

    ☐

    (13)   

    Percent of class represented by amount in Row (11)

     

    32.3%*

    (14)   

    Type of reporting person (see instructions)

     

    IN

     

    *

    Based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 11 of 14

     

    This Amendment No. 8 (the “Amendment”) amends and supplements the Schedule 13D filed by the Reporting Persons on July 1, 2022, as amended on October 3, 2023, February 7, 2024, February 26, 2024, April 29, 2024, May 7, 2024, June 14, 2024 and July 1, 2024 (collectively, the “Original Schedule 13D” and, as amended and supplemented by this Amendment, this “Statement”), with respect to the Common Stock. Capitalized terms used in this Amendment and not otherwise defined shall have the same meanings ascribed to them in the Original Schedule 13D.

    Item 4. Purpose of Transaction.

    Item 4 of the Original Schedule 13D is amended and supplemented by adding the following:

    On July 1, 2024, the Investors submitted the July 1 Waiver Request to the Issuer, and the Issuer promptly approved the submission by the Investors or their affiliates of confidential private acquisition proposals to the Issuer and compliance with associated disclosure requirements. On July 2, 2024, New Mountain Capital L.L.C., on behalf of certain managed funds, delivered to the Special Committee (the “Special Committee”) of the Board of Directors of the Issuer (the “Board”) a non-binding proposal (the “Proposal”) to acquire all of the outstanding shares of the Issuer’s Common Stock not owned by the Investors for a purchase price of $13.25 per share in cash (the “Proposed Transaction”).

    No response has been provided to the Proposal. Any definitive agreement entered into in connection with the Proposed Transaction would be subject to customary closing conditions, including approval by the Special Committee and the Board, stockholder approval and approval by (or clearance from) any applicable regulatory authorities. No assurances can be given that a definitive agreement will be reached, that the Proposed Transaction will be consummated, or that the Proposed Transaction will be consummated on the terms set forth in the Proposal. While the Proposal and the Proposed Transaction remain under consideration by the Issuer, the Reporting Persons and their affiliates expect to respond to inquiries from, and, if invited, to negotiate the terms of the Proposal with, the Issuer and its representatives. The Reporting Persons do not intend to provide additional disclosure regarding the Proposal or the Proposed Transaction unless and until a definitive agreement has been reached, or unless disclosure is otherwise required under applicable U.S. securities laws.

    The Reporting Persons and their affiliates reserve the right to modify the Proposal at any time. Subject to the restrictions set forth in the Investor Rights Agreement, the Reporting Persons and their affiliates reserve the right to formulate other plans or make other proposals which could result in one or more of the transactions, events or actions specified in clauses (a) through (j) of Item 4 of Schedule 13D, and to modify or withdraw any such plan or proposal at any time. Subject to the restrictions set forth in the Investor Rights Agreement, if the Proposed Transaction is not consummated, the Reporting Persons and their affiliates will continue to regularly review and assess their investment in the Issuer and, depending on market conditions and other factors, may determine, from time to time, to engage in any of the events set forth in clauses (a) through (j) of Item 4 of Schedule 13D.

    The foregoing description of the Proposal does not purport to be complete and is subject to, and qualified in its entirety by, reference to the full text of the Proposal, which is attached hereto as Exhibit 9.

    Item 5. Interest in Securities of the Issuer.

    Item 5 of the Original Schedule 13D is amended and restated in its entirety as follows:

    The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Statement and the information set forth or incorporated in Items 2, 3, 4 and 6 is incorporated by reference in its entirety into this Item 5.

    (a) and (b) The percentages in this Item 5 and in other provisions of this Statement relating to beneficial ownership of Common Stock are based on based on 421,255,230 shares of Common Stock outstanding as of May 8, 2024, as reported by the Issuer in the Form 10-Q.

    (c) None of the Reporting Persons has effected any transaction in the shares of Common Stock during the past 60 days.


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 12 of 14

     

    (d) No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Common Stock covered by this Statement.

    (e) Not applicable.

    Item 7. Materials to be Filed as Exhibits.

    Item 7 of the Original Schedule 13D is amended and supplemented by adding the following:

     

    Exhibit
    Number
      

    Description of Exhibit

    9.    Proposal, dated July 2, 2024.


    Signatures

    After reasonable inquiry and to the best knowledge and belief of the undersigned, such person certifies that the information set forth in this Statement with respect to such person is true, complete and correct.

    Dated: July 2, 2024

     

      CoyCo 1, L.P.
    By:   /s/ Adam B. Weinstein
      Name: Adam B. Weinstein
      Title: Vice President
      CoyCo 2, L.P.; By its General Partner CoyCo GP, L.L.C.
    By:   /s/ Adam B. Weinstein
      Name: Adam B. Weinstein
      Title: Vice President
      CoyCo GP, L.L.C.
    By:   /s/ Adam B. Weinstein
      Name: Adam B. Weinstein
      Title: Vice President
      New Mountain Partners V (AIV-D), L.P.; By its General Partner New Mountain Investments V, L.L.C.
    By:   /s/ Adam B. Weinstein
      Name: Adam B. Weinstein
      Title: Authorized Signatory
      New Mountain Investments V, L.L.C.
    By:   /s/ Adam B. Weinstein
      Name: Adam B. Weinstein
      Title: Authorized Signatory
      New Mountain Capital, L.L.C.; By its Managing Member New Mountain Capital Group, L.P.; By its General Partner NM Holdings GP, L.L.C.
    By:   /s/ Adam B. Weinstein
      Name: Adam B. Weinstein
      Title: Authorized Signatory
      New Mountain Capital Group, L.P.; By its General Partner NM Holdings GP, L.L.C.
    By:   /s/ Adam B. Weinstein
      Name: Adam B. Weinstein
      Title: Authorized Signatory


    CUSIP No. 77634L 105

     

       Schedule 13D    Page 14 of 14

     

      NM Holdings GP, L.L.C.
    By:   /s/ Adam B. Weinstein
      Name: Adam B. Weinstein
      Title: Authorized Signatory
    Steven B. Klinsky
      /s/ Steven B. Klinsky
    Get the next $RCM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RCM

    DatePrice TargetRatingAnalyst
    8/8/2024Overweight → Equal-Weight
    Morgan Stanley
    8/1/2024Overweight → Equal-Weight
    Stephens
    8/1/2024Outperform → Market Perform
    Leerink Partners
    8/1/2024Buy → Hold
    Jefferies
    4/10/2024Overweight → Sector Weight
    KeyBanc Capital Markets
    3/20/2024$16.00Neutral → Buy
    Citigroup
    2/26/2024$14.00Outperform
    Leerink Partners
    1/3/2024$14.00Overweight
    Barclays
    More analyst ratings

    $RCM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • TowerBrook and CD&R Complete Acquisition of R1 RCM

      MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. ("R1"), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners ("TowerBrook") and Clayton, Dubilier & Rice ("CD&R") have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion. With the completion of the transaction, R1's common stock has ceased trading and w

      11/19/24 9:06:28 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Shift4 Payments Set to Join the S&P MidCap 400

      NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

      11/15/24 6:15:00 PM ET
      $FOUR
      $RCM
      $SPGI
      Business Services
      Consumer Discretionary
      Other Consumer Services
      Finance: Consumer Services
    • R1 RCM Reports Third Quarter 2024 Results

      MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

      11/5/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director New Mountain Capital, L.L.C. disposed of $1,944,593,908 worth of shares (135,985,588 units at $14.30) (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/22/24 4:05:14 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Director Dill David M returned $708,165 worth of shares to the company (49,522 units at $14.30), closing all direct ownership in the company (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/19/24 5:37:21 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Director Henneman John B Iii returned $1,255,040 worth of shares to the company (87,765 units at $14.30), closing all direct ownership in the company (SEC Form 4)

      4 - R1 RCM Inc. /DE (0001910851) (Issuer)

      11/19/24 5:35:59 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      11/22/24 4:06:56 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      11/19/24 4:36:38 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • Amendment: SEC Form SC 13D/A filed by R1 RCM Inc.

      SC 13D/A - R1 RCM Inc. /DE (0001910851) (Subject)

      8/5/24 7:31:56 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • R1 RCM downgraded by Morgan Stanley

      Morgan Stanley downgraded R1 RCM from Overweight to Equal-Weight

      8/8/24 8:58:18 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM downgraded by Stephens

      Stephens downgraded R1 RCM from Overweight to Equal-Weight

      8/1/24 9:39:53 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM downgraded by Leerink Partners

      Leerink Partners downgraded R1 RCM from Outperform to Market Perform

      8/1/24 9:39:53 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    SEC Filings

    See more
    • SEC Form POSASR filed by R1 RCM Inc.

      POSASR - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:26:18 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 POS filed by R1 RCM Inc.

      S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:18:28 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • SEC Form S-8 POS filed by R1 RCM Inc.

      S-8 POS - R1 RCM Inc. /DE (0001910851) (Filer)

      11/19/24 4:17:27 PM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Financials

    Live finance-specific insights

    See more
    • R1 RCM Reports Third Quarter 2024 Results

      MURRAY, Utah, Nov. 05, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended September 30, 2024. Third Quarter 2024 Results: Revenue of $656.8 million, up $84.0 million or 14.7% compared to the same period last year.GAAP net loss of $19.9 million, compared to net income of $1.3 million in the same period last year.Adjusted EBITDA of $148.2 million, compared to adjusted EBITDA of $161.5 million in the same period last year. The quarter reflects impacts to both revenue and costs as

      11/5/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM Reports Second Quarter 2024 Results

      MURRAY, Utah, Aug. 07, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months ended June 30, 2024. Second Quarter 2024 Results: Revenue of $627.9 million, up $67.2 million or 12.0% compared to the same period last year.GAAP net loss of $7.6 million, compared to net loss of $1.0 million in the same period last year.Adjusted EBITDA of $156.1 million, compared to adjusted EBITDA of $142.9 million in the same period last year. The quarte

      8/7/24 7:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary
    • R1 RCM to be Acquired by TowerBrook and CD&R for $8.9 Billion

      MURRAY, Utah, Aug. 01, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that it has entered into a definitive agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice ("CD&R"), in an all-cash transaction with an enterprise value of approximately $8.9 billion. An investment vehicle controlled by TowerBrook is currently the beneficial owner of approximately 36% of the Company's outstanding shares of common stock, including the warrant held by TowerBrook.

      8/1/24 7:30:34 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary

    $RCM
    Leadership Updates

    Live Leadership Updates

    See more
    • Shift4 Payments Set to Join the S&P MidCap 400

      NEW YORK, Nov. 15, 2024 /PRNewswire/ -- Shift4 Payments Inc. (NYSE:FOUR) will replace R1 RCM Inc. (NASD:RCM) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 20. TowerBrook Capital Partners and Clayton, Dublier & Rice will acquire R1 RCM in a transaction expected to be completed on or about November 19. Following is a summary of the change that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 20, 2024 S&P MidCap 400 Addition Shift4 Payments FOUR Financials S&P MidCap 400 Deletion R1 RCM RCM Health Care For more information about S&P Dow Jones Indices, ple

      11/15/24 6:15:00 PM ET
      $FOUR
      $RCM
      $SPGI
      Business Services
      Consumer Discretionary
      Other Consumer Services
      Finance: Consumer Services
    • James Hardie Industries Announces Global Leadership Appointment

      Rachel Wilson appointed as Chief Financial Officer (CFO) James Hardie Industries plc ((ASX: JHX, NYSE:JHX), the world's #1 producer and marketer of high-performance fiber cement and fiber gypsum building solutions, today announced the appointment of Ms. Rachel Wilson as Chief Financial Officer, effective immediately. As a member of the global executive team, Ms. Wilson will report directly to Chief Executive Officer Aaron Erter. Ms. Wilson was appointed after Jason Miele stepped down as Chief Financial Officer. Mr. Miele will remain with the Company for three months as an advisor to the Chief Executive Officer for special projects and will thereafter depart the organization. "I would li

      8/16/23 9:50:00 PM ET
      $JHX
      $RCM
      Building Materials
      Industrials
      Other Consumer Services
      Consumer Discretionary
    • R1 Announces Appointment of Agnes Bundy Scanlan to Board of Directors

      MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company's board of directors, effective August 11, 2021. Ms. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group LLC, a regulatory risk management advisory firm, since May 2020. Prior to this role, Ms. Bundy Scanlan served as senior advisor at Trelian

      8/12/21 8:00:00 AM ET
      $RCM
      Other Consumer Services
      Consumer Discretionary